Sign Out
Pharmacology: Antiplasminic activity: Transic inhibits both actions of plasminogen activator and plasmin. Antiplasminic activity of Transic is proved by various measurements in vitro, and by determinations of plasmin activity in the blood and local activity after administering to the human body as well.
Hemostatic activity: Transic prevents degradation of fibrin, degeneration of platelet, increase of vascular fragility and splitting of coagulation factors. These effects are clinically proved by reduction of bleeding amount, shortening of bleeding time and bleeding period in days.
Continue with Google